`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION
`Patent Owner
`
`Case IPR2021-00816
`U.S. Patent No. 9,220,631
`
`MOTION FOR PRO HAC VICE ADMISSION
`UNDER 37 C.F.R. § 42.10
`
`
`
`Regeneron Pharmaceuticals, Inc. files this motion for Pro Hac Vice admission
`
`under 37 C.F.R § 42.10(c), as authorized in the Notice of Filing Date Accorded to
`
`Petition, Paper No. 3. The Board requires that such motions be filed in accordance
`
`with the “Order – Authorizing Motion for Pro Hac Admission” in Case IPR2013-
`
`00639, Paper 7 (“Order”).
`
`Petitioner respectfully requests that the Board recognize Petra Scamborova as
`
`counsel pro hac vice during this proceeding.
`
`1.
`
`
`
`Time for Filing
`
`This motion for pro hac vice admission is filed no sooner that twenty-one (21)
`
`days after service of the petition, as required by the Order.
`
`2.
`
`
`
`Statement of Facts
`
`The following statement of facts shows that there is good cause for the Board to
`
`recognize Dr. Petra Scamborova pro hac vice.
`
`
`
`Dr. Scamborova has a Bachelor of Arts in Biochemistry, Master of Philosophy
`
`in Biochemistry, and a Doctor of Philosophy in Molecular Biophysics and
`
`Biochemistry, as well as 15 years of experience as a patent litigation attorney. She has
`
`been involved in numerous patent litigations, including litigation relating to VEGF-
`
`antagonists, and has extensive experience with the VEGF-antagonist technology at
`
`issue in this case. Dr. Scamborova’s biography is attached hereto as Exhibit 1096.
`
`
`
`Further, counsel for patent owner does not oppose Dr. Scamborova appearing as
`
`pro hac vice during this proceeding.
`
`
`
`1
`
`
`
`2.
`
`Affidavit or Declaration of Individual Seeking to Appear
`
`This motion for Pro Hac Vice Admission is accompanied by the Declaration of
`
`Dr. Petra Scamborova (Ex. 1095), as required by authorization of the Board.
`
`Dated: December 22, 2021
`
`Respectfully submitted,
`
`/Elizabeth Stotland Weiswasser/
`Elizabeth S. Weiswasser (Reg. No. 73,760)
`Anish R. Desai (Reg. No. 73,760)
`Natalie Kennedy (Reg. No. 68,511)
`Andrew Gesior (Reg. No. 76,588)
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8000
`F: 212-310-8007
`E: Regeneron.IPR.Service@weil.com
`
`Brian E. Ferguson (Reg. No. 36,801)
`Christopher Pepe (Reg. No. 73,851)
`Weil, Gotshal & Manges LLP
`2001 M Street NW, Suite 600
`Washington, DC 20036
`T: 202-682-7000
`F: 202-857-0940
`E: Regeneron.IPR.Service@weil.com
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`I hereby certify that on December 22, 2021, copies of the foregoing
`
`PETITIONER’S MOTION FOR PRO HAC VICE ADMISSION UNDER 37
`
`C.F.R. § 42.10 was served via electronic mail, upon the following:
`
`Elizabeth J. Holland
`Linnea Cipriano
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`EHolland@goodwinlaw.com
`LCipriano@goodwinlaw.com
`
`William G. James
`Goodwin Procter LLP
`1900 N Street, N.W.
`Washington, D.C. 20036
`WJames@goodwinlaw.com
`
`Joshua Weinger
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`JWeinger@goodwinlaw.com
`
`DG-NovartisPFS@goodwinlaw.com
`
`/Lauren McDuffie/
`Lauren McDuffie
`Senior IP Paralegal
`Weil, Gotshal & Manges LLP
`2001 M Street N.W., Suite 600
`Washington, D.C. 20036
`202-682-7000
`lauren.mcduffie@weil.com
`
`